Skip to main content

Closed

PRLD: Prelude Therapeutics Incorporated Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

78thpctl

Volume

0.62×avg

Market Cap

261.89MUSD

P/E Ratio

-4.3TTM

Div Yield

-ann

Prelude Therapeutics Incorporated

PRLDNASDAQ Global Select·USD·Closed

Prelude Therapeutics Incorporated

PRLDNASDAQ·USD·Closed

$4.60

−8.91%

$4.60

−$0.45 (8.91%)

52W Range

78thpctl

Volume

0.62×avg

Mkt Cap

261.89MUSD

P/E

-4.3TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings